Given that approximately 85% of sporadic CRCs have deregulated canonical Wnt/β-catenin signaling [15], we hypothesized there would be a functional interplay between EBP50 and β-catenin during CRC progression through modulation of EMT-related BD features. The gene discussed is NHERF1; the disease is colorectal carcinoma.